Multiple Sclerosis Discovery Forum

Inspiring Connections

Most Viewed Papers

Association of Cerebrospinal Fluid Levels of Lateral Olfactory Tract Usher Substance (LOTUS) With Disease Activity in Multiple Sclerosis.
Ultra-High-Field MRI Visualization of Cortical Multiple Sclerosis Lesions with T2 and T2*: A Postmortem MRI and Histopathology Study.
Chronic Inflammatory Demyelinating Polyneuropathy Manifesting as Neuropathy With Liability to Pressure Palsies: A Case Report.
Fast facts: multiple sclerosis.
Role of Formyl Peptide Receptors (FPR) in Abnormal Inflammation Responses Involved in Neurodegenerative Diseases.
[Mitoxantrone role in treatment of primary progressive multiple sclerosis].
Inflammatory Cytokines Are Involved in Focal Demyelination in Leprosy Neuritis.
Dysregulation of sphingosine 1 phosphate receptor-1 (S1P1) signaling and regulatory lymphocyte-dependent immunosuppression in a model of post-fingolimod MS rebound.
[Characteristics of arterial tension in multiple sclerosis (biometric-statistical data)].
Vitamin D in multiple sclerosis: implications for assessment and treatment.
Prevalence of Sexual Dysfunctions Among Women with Multiple Sclerosis.
Th17 and Non-Classic Th1 Cells in Chronic Inflammatory Disorders: Two Sides of the Same Coin.
The best clinical paper on multiple sclerosis in 2014: Herodotus and Chataway - Commentary.
Prediction of disease severity in neuromyelitis optica by the levels of IL-6 produced during remission phase.
Stress-stimulated volitional coping competencies and depression in multiple sclerosis.
Prevalence of chronic cerebrospinal venous insufficiency in multiple sclerosis: a blinded sonographic evaluation.
Gallic acid-based small-molecule inhibitors of JC and BK polyomaviral infection.
Initiation of Anti-TNF Therapy and the Risk of Optic Neuritis: From the Safety Assessment of Biologic ThERapy (SABER) Study.
The ribosomal S6 kinase inhibitor BI-D1870 ameliorated experimental autoimmune encephalomyelitis in mice.
A Psychometric Validation of Two Brief Measures to Assess Palliative Need in Patients Severely Affected by Multiple Sclerosis.
Compare before deciding. Treatment of relapsing-remitting multiple sclerosis.
[Clinically isolated syndrome.]
IL-6 and IL-17 synergistically promote viral persistence by inhibiting cellular apoptosis and cytotoxic T cell function.
Immune cell trafficking across the barriers of the central nervous system in multiple sclerosis and stroke.
Sexual function in women with multiple sclerosis.

Pages